{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T06:40:10Z","timestamp":1745649610109,"version":"3.40.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03750-8","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T14:03:45Z","timestamp":1728569025000},"page":"2104-2112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Salvage reirradiation for recurrent glioblastoma: a retrospective case series analysis"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7457-0589","authenticated-orcid":false,"given":"Anna","family":"Lucas Calduch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7328-4767","authenticated-orcid":false,"given":"Miquel","family":"Maci\u00e0 Garau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9089-4807","authenticated-orcid":false,"given":"Salvador","family":"Vill\u00e0 Freixa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1379-0921","authenticated-orcid":false,"given":"Nagore","family":"Garc\u00eda Exp\u00f3sito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7608-3040","authenticated-orcid":false,"given":"Ignasi","family":"Modolell Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0468-5150","authenticated-orcid":false,"given":"Carles","family":"Maj\u00f3s Torr\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-8291","authenticated-orcid":false,"given":"Albert","family":"Pons Escoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-7897","authenticated-orcid":false,"given":"Carlos","family":"Mes\u00eda Barroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5115-6628","authenticated-orcid":false,"given":"Noelia","family":"Vilari\u00f1o Quintela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4033-530X","authenticated-orcid":false,"given":"Aleix","family":"Rossell\u00f3 G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-3853","authenticated-orcid":false,"given":"Gerard","family":"Plans Ahicart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5891-3935","authenticated-orcid":false,"given":"Mar\u00eda","family":"Mart\u00ednez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-971X","authenticated-orcid":false,"given":"Anna","family":"Esteve G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6895-5047","authenticated-orcid":false,"given":"Jordi","family":"Bruna Escuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"issue":"18","key":"3750_CR1","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2009.25.6941","volume":"28","author":"SE Fogh","year":"2010","unstructured":"Fogh SE, Andrews DW, Glass J, Curran W, Glass C, Champ C, et al. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol. 2010;28(18):3048\u201353. https:\/\/doi.org\/10.1200\/JCO.2009.25.6941.","journal-title":"J Clin Oncol"},{"key":"3750_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.radonc.2021.12.019","volume":"167","author":"P Navarria","year":"2022","unstructured":"Navarria P, Pessina F, Clerici E, Bellu L, Franzese C, Franzini A, et al. Re-irradiation for recurrent high grade glioma (HGG) patients: results of a single arm prospective phase 2 study. Radiother Oncol. 2022;167:89\u201396. https:\/\/doi.org\/10.1016\/j.radonc.2021.12.019.","journal-title":"Radiother Oncol"},{"issue":"1","key":"3750_CR3","doi-asserted-by":"publisher","first-page":"CD013579","DOI":"10.1002\/14651858.CD013579.pub2","volume":"5","author":"C McBain","year":"2021","unstructured":"McBain C, Lawrie TA, Rogozi\u0144ska E, Kernohan A, Robinson T, Jefferies S. Treatment options for progression or recurrence of glioblastoma: a network meta-analysis. Cochrane Database Syst Rev. 2021;5(1):CD013579. https:\/\/doi.org\/10.1002\/14651858.CD013579.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"3750_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.critrevonc.2018.03.024","volume":"126","author":"S Scoccianti","year":"2018","unstructured":"Scoccianti S, Francolini G, Carta GA, Greto D, Detti B, Simontacchi G, et al. Re-irradiation as salvage treatment in recurrent glioblastoma: a comprehensive literature review to provide practical answers to frequently asked questions. Crit Rev Oncol Hematol. 2018;126:80\u201391. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.03.024.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"17","key":"3750_CR5","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.3390\/cancers15174279","volume":"15","author":"MA Vaz-Salgado","year":"2023","unstructured":"Vaz-Salgado MA, Villamayor M, Albarr\u00e1n V, Al\u00eda V, Sotoca P, Chamorro J, et al. Recurrent glioblastoma: a review of the treatment options. Cancers (Basel). 2023;15(17):4279. https:\/\/doi.org\/10.3390\/cancers15174279.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"3750_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1200\/JCO.22.00164","volume":"41","author":"CI Tsien","year":"2023","unstructured":"Tsien CI, Pugh SL, Dicker AP, Raizer JJ, Matuszak MM, Lallana EC, et al. NRG Oncology\/RTOG1205: a randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma. J Clin Oncol. 2023;41(6):1285\u201395. https:\/\/doi.org\/10.1200\/JCO.22.00164.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3750_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11060-023-04441-0","volume":"164","author":"R Marwah","year":"2023","unstructured":"Marwah R, Xing D, Squire T, Soon YY, Gan HK, Ng SP. Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity. J Neurooncol. 2023;164(3):505\u201324. https:\/\/doi.org\/10.1007\/s11060-023-04441-0.","journal-title":"J Neurooncol"},{"issue":"2","key":"3750_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11060-019-03101-6","volume":"142","author":"C Straube","year":"2019","unstructured":"Straube C, Antoni S, Gempt J, Zimmer C, Meyer B, Schlegel J, et al. Re-irradiation in elderly patients with glioblastoma: a single institution experience. J Neurooncol. 2019;142(2):327\u201335. https:\/\/doi.org\/10.1007\/s11060-019-03101-6.","journal-title":"J Neurooncol"},{"issue":"2","key":"3750_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11060-024-04607-4","volume":"167","author":"MT Yilmaz","year":"2024","unstructured":"Yilmaz MT, Kahvecioglu A, Yazici G, Mohammadipour S, Kertmen N, Cifci GC, et al. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years\u2019 experience of a single center. J Neurooncol. 2024;167(2):295\u2013303. https:\/\/doi.org\/10.1007\/s11060-024-04607-4.","journal-title":"J Neurooncol"},{"issue":"1","key":"3750_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.14791\/btrt.2020.8.e10","volume":"8","author":"MS Kim","year":"2020","unstructured":"Kim MS, Lim J, Shin HS, Cho KG. Re-Irradiation and its contribution to good prognosis in recurrent glioblastoma patients. Brain Tumor Res Treat. 2020;8(1):29\u201335. https:\/\/doi.org\/10.14791\/btrt.2020.8.e10.","journal-title":"Brain Tumor Res Treat."},{"issue":"10","key":"3750_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396. https:\/\/doi.org\/10.1056\/NEJMoa043330.","journal-title":"N Engl J Med"},{"issue":"21","key":"3750_CR12","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1200\/JCO.2017.72.7511","volume":"35","author":"PY Wen","year":"2017","unstructured":"Wen PY, Chang SM, Van den Bent MJ, Vogelbaum MA, Macdonald DR, Lee EQ. Response assessment in neuro-oncology clinical trials. J Clin Oncol. 2017;35(21):2439\u201349. https:\/\/doi.org\/10.1200\/JCO.2017.72.7511.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3750_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-018-03064-0","volume":"142","author":"F Kazmi","year":"2019","unstructured":"Kazmi F, Soon YY, Leong YH, Koh WY, Vellayappan B. Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis. J Neurooncol. 2019;142(1):79\u201390. https:\/\/doi.org\/10.1007\/s11060-018-03064-0.","journal-title":"J Neurooncol"},{"issue":"4","key":"3750_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.prro.2016.03.007","volume":"6","author":"AR Cabrera","year":"2016","unstructured":"Cabrera AR, Kirkpatrick JP, Fiveash JB, Shih HA, Koay EJ, Lutz S, et al. Radiation therapy for glioblastoma: executive summary of an American society for radiation oncology evidence-based clinical practice guideline. Pract Radiat Oncol. 2016;6(4):217\u201325. https:\/\/doi.org\/10.1016\/j.prro.2016.03.007.","journal-title":"Pract Radiat Oncol"},{"issue":"11","key":"3750_CR15","first-page":"883","volume":"91","author":"F Dhermain","year":"2004","unstructured":"Dhermain F, de Crevoisier R, Parker F, Cioloca C, Kaliski A, Beaudre A, et al. Role of radiotherapy in recurrent gliomas. Bull Cancer. 2004;91(11):883\u20139.","journal-title":"Bull Cancer"},{"issue":"3","key":"3750_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/COC.0b013e31815e3fdc","volume":"31","author":"C Nieder","year":"2008","unstructured":"Nieder C, Astner ST, Mehta MP, Grosu AL, Molls M. Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma. Am J Clin Oncol. 2008;31(3):300\u20135. https:\/\/doi.org\/10.1097\/COC.0b013e31815e3fdc.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"3750_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijrobp.2017.08.038","volume":"100","author":"W Shi","year":"2018","unstructured":"Shi W, Scannell Bryan M, Gilbert MR, Mehta MP, Blumenthal DT, Brown PD, et al. Investigating the effect of reirradiation or systemic therapy in patients with glioblastoma after tumor progression: a secondary analysis of NRG oncology\/radiation therapy oncology group trial 0525. Int J Radiat Oncol Biol Phys. 2018;100(1):38\u201344. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.08.038.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"3750_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","volume":"79","author":"VA Levin","year":"2011","unstructured":"Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011;79(5):1487\u201395. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.12.061.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3750_CR19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s11060-016-2267-x","volume":"130","author":"O Schnell","year":"2016","unstructured":"Schnell O, Thorsteinsdottir J, Fleischmann DF, Lenski M, Abenhardt W, Giese A, et al. Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma. J Neurooncol. 2016;130(3):591\u20139. https:\/\/doi.org\/10.1007\/s11060-016-2267-x.","journal-title":"J Neurooncol"},{"issue":"2","key":"3750_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11060-014-1394-5","volume":"117","author":"M Flieger","year":"2014","unstructured":"Flieger M, Ganswindt U, Schwarz SB, Kreth FW, Tonn JC, la Foug\u00e8re C, et al. Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option. J Neurooncol. 2014;117(2):337\u201345. https:\/\/doi.org\/10.1007\/s11060-014-1394-5.","journal-title":"J Neurooncol"},{"issue":"1","key":"3750_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijrobp.2008.10.043","volume":"75","author":"PH Gutin","year":"2009","unstructured":"Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, et al. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2009;75(1):156\u201363. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.10.043.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3750_CR22","unstructured":"European Organisation for Research and Treatment of Cancer \u2013 EORTC. Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study (LEGATO). ClinicalTrials.gov Identifier: NCT05904119. Available online: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05904119 (accessed May 6, 2024)."},{"issue":"2","key":"3750_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11060-008-9607-4","volume":"89","author":"SE Combs","year":"2008","unstructured":"Combs SE, Bischof M, Welzel T, Hof H, Oertel S, Debus J, et al. Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. J Neurooncol. 2008;89(2):205\u201310. https:\/\/doi.org\/10.1007\/s11060-008-9607-4.","journal-title":"J Neurooncol"},{"issue":"3","key":"3750_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s11060-010-0446-8","volume":"103","author":"G Minniti","year":"2011","unstructured":"Minniti G, Armosini V, Salvati M, Lanzetta G, Caporello P, Mei M, et al. Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma. J Neurooncol. 2011;103(3):683\u201391. https:\/\/doi.org\/10.1007\/s11060-010-0446-8.","journal-title":"J Neurooncol"},{"issue":"5","key":"3750_CR25","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/s0360-3016(99)00336-3","volume":"45","author":"KH Cho","year":"1999","unstructured":"Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys. 1999;45(5):1133\u201341. https:\/\/doi.org\/10.1016\/s0360-3016(99)00336-3.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3750_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ijrobp.2005.01.056","volume":"63","author":"AL Grosu","year":"2005","unstructured":"Grosu AL, Weber WA, Franz M, St\u00e4rk S, Piert M, Thamm R, et al. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)\/CT\/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63(2):511\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.01.056.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3750_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11060-012-0999-9","volume":"111","author":"G Minniti","year":"2013","unstructured":"Minniti G, Scaringi C, De Sanctis V, Lanzetta G, Falco T, Di Stefano D, et al. Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas. J Neurooncol. 2013;111(2):187\u201394. https:\/\/doi.org\/10.1007\/s11060-012-0999-9.","journal-title":"J Neurooncol"},{"issue":"6","key":"3750_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.clineuro.2011.02.001","volume":"113","author":"B Kim","year":"2011","unstructured":"Kim B, Soisson E, Duma C, Chen P, Hafer R, Cox C, et al. Treatment of recurrent high grade gliomas with hypofractionated stereotactic image-guided helical tomotherapy. Clin Neurol Neurosurg. 2011;113(6):509\u201312. https:\/\/doi.org\/10.1016\/j.clineuro.2011.02.001.","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03750-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03750-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03750-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T06:03:21Z","timestamp":1745647401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03750-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["3750"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03750-8","relation":{},"ISSN":["1699-3055"],"issn-type":[{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}